FDA Inspection 1222829 — Mahatma Gandhi Cancer Hospital And Shiv Cancer Institute
The FDA completed an inspection of Mahatma Gandhi Cancer Hospital And Shiv Cancer Institute on Oct 26, 2023 in Miraj. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 26, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miraj (India)
Additional Details
Clinical BA/BE